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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S396Purpose: To examine the associations of elevated serum c-reactive
protein (CRP) and erythrocyte sedimentation rate (ESR) with radio-
graphic progression in patients with established knee osteoarthritis
(OA), over two years.
Methods: Data from 186 patients with knee OA were gathered at
baseline and at two-years follow up. CRP (mg/l) and ESR (mm/l) were
measured in serum from patients’ blood. Inﬂammatory markers were
considered elevated if CRP>3mg/l or ESR20mm/h (1). Radiographs of
the knees were used to assess joint space narrowing (JSN), ostephytes,
sclera and cysts in the tibiofemoral (medial and lateral) and patellofe-
moral compartments, Kellgren and Lawrence (KL) score (0-4) was also
determined. Progression was deﬁned as an increase in 1 in the
radiographic features assessed or total KL score in either knee during
follow-up. The association of inﬂammatory markers with radiographic
progression was analyzed using uni- and multivariate linear regression
models. Full models were adjusted for age, gender, NSAIDs use, BMI
change, comorbidities change and higher radiographic feature or KL
score at baseline.
Results: Patients with elevated CRP and ESR values at both baseline and
two-years follow-up exhibited no progression in KL score compared
with the group with not elevated values at both times of assessment,
before or after adjustment for relevant confounders. When analyzing
the various futures (JSN, ostephytes, sclera and cysts),a signiﬁcant
association was found only between elevated CRP (OR¼2.9, p¼0.048)
and ESR (OR¼4.42, p¼0.017) values at both times of assessment and JSN
progression in the patellofemoral compartment compared with the
group with not elevated levels. No association was found between
elevated values of CRP and ESR at baseline and at follow-up with
radiographic progression of the other features analyzed in the three
compartments assessed.
Conclusions: Overall this study provides no evidence that persistently
elevated CRP and ESR values are related to a radiographic progression in
patients with established knee OA, over two years. Our results are in
line with previous evidence which has suggested no association
between elevated inﬂammatory markers and progression of OA (2).
Future studies should be performed analyzing this association with
local markers of inﬂammation, instead of systemic inﬂammatory
markers. Additionally, considering the slow progression of the disease, a
longer follow-up period might be recommended.
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SHOE TORSIONAL RESISTANCE RELATED TO MEDIAL KNEE OA
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Chicago, IL, USA
Purpose: Recent evidence suggests that footwear can signiﬁcantly
affect dynamic knee loading and that ﬂat, ﬂexible shoes may result in
lower knee loads compared to more supportive, stiff-soled shoes. Here,
we evaluate the torsional stiffness of the shoe compared longitudinal
effects on knee loading over 6 months.
Methods: Subjects with radiographic (KL grades  2) and symptomatic
(at least 30mm pain of 100mm scale while walking) medial compart-
ment knee OAwere recruited and randomized to receive a ﬂexible soled
shoe (mobility shoe) or identical appearing “control” shoe with stiffer
sole. The frontal plane torsional stiffness of the shoe was evaluated
using a biomaterial testing system. Investigators and participants were
blinded to shoe assignment. Baseline gait analyses were performed
using an optoelectronic camera system and multi-component force
plate in subjects’ “own shoes”, study shoes, and barefoot. Subjects were
instructed to wear the study shoes at least 6 hours/day for 6 days/week.
Gait analysis was repeated at 6, 12 and 24 weeks. The peak knee
adduction moment (KAM), a validated marker of medial compartment
loading, was evaluated. An intent-to-treat analysis was performed with
imputation of missing data using a hot deck method (Rubin, 1987).
Repeated measures analysis of variance compared the two arms andplanned contrasts were used to further analyze the data and load
reductions at various time points.
Results: 22 participants (13 women, mean age 557 years) were
assigned to the mobility shoe and 28 (21 women, mean age 558 years)
to the control shoe. The median modulus of elasticity of the treatment
group shoes was 0.250.07 compared to the control shoe 0.941.05
(p¼0.009). There was a strong correlation between the reduction in the
KAM and torsional stiffness from baseline to 24 months in treatment
group and control group (0.88 and 0.89 respectively p¼0.03) There
were differences in Peak KAM over time in the treatment group vs.
control with the more ﬂexible shoe producing reductions while the
control increased moments (-0.25 0.95 and 0.09 0.95 %BW*ht
respectively, rmANOVA, p¼0.002).
Conclusions: This double-blind randomized controlled trial suggests
that loading of the medial knee is directly related to the torsional
stiffness the shoe. The use of shoes with ﬂexibility in the frontal plane
over 6 months results in signiﬁcant reductions in medial knee loading
compared to stiffer shoes with greater torsional resistance. Thus, eval-
uating the shoe for torsional resistance may help determine which shoe
would be an effective biomechanical intervention for the management
of knee OA.
706
INTRA-ARTICULAR INJECTION THERAPY FOR PATIENTS WITH HIP
OSTEOARTHRITIS. A SYSTEMATIC REVIEW OF THE LITERATURE
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Purpose: In current systematic review we will compare the efﬁcacy of
several intra-articular treatment options (CS, HA, PRP and placebo) in
patients with hip OA. The goal of this review is to give recom-
mendations regarding the most optimal treatment(s) of these patients
and formulate some recommendations for future research.
Methods: The following databases were searched: MEDLINE (period
1966 to June 2013), Cochrane Database of Systematic Reviews (1988 to
June 2013), Cochrane Clinical Trial Register (1988 to June 2013), EMBASE
(January 1988 to June 2013) and the WHO clinical trial register to
identify all articles concerning the intra-articular injection therapy for
hip OA.Search term (‘Hyaluronic Acid/administration and dosage’
[MeSH] OR ‘Hyaluronic Acid/diagnostic use’ [MeSH] OR ‘Hyaluronic
Acid/therapeutic use’ [MeSH] OR ‘Hyaluronic Acid/therapy’ [MeSH]) OR
corticosteroids OR platelet rich plasma OR stem cells AND hip)
Results: Of the 1781 studies found using the search terms mentioned
above, 36 were screened for eligibility. We included 10 RCTs (1 com-
pared CS and HA, the other compared CS or HA with different amounts
of CS, with other brands of HA, placebo and/or intra-articular admin-
istered anaesthetics) and 26 cohort series (23 HA, 1 CS ,2 PRP). Most
studies determined the efﬁcacy of intra-articular administered HA (29
papers). The efﬁcacy of intra-articular CS and PRP were studied in 7 and
2 papers, respectively. No studies were found about the use of intra-
articular mesenchymal stem cells or other treatments in patients with
hip OA. In 6 studies the results of patient treated with placebo were
reported. Of the 36 available studies 32 could be used to calculate the
effect sizes. Only the effect sizes of the treatments reported in the
studies of Flanagan et al and Migilore et al (2005) could not be calcu-
lated due to the lack of reporting data. The study of Conrozier et al
(2009) could not be used for pooling due to different durations of fol-
low-up of the patients and the study of Conrozier et al (2006) showed
the results of the same patients reported in the study of Conrozier et al
(2003). The treatment results of a total of 1979 patients could be used in
this review (499 CS, 1261 HA, 159 placebo and 60 PRP).In ﬁgure 1-4 the
calculated effect sizes of the different treatments, including placebo, at
different follow-up are shown.
Pooling the data of the different treatment options showed besides a
large heterogeneity regarding product of treatment, treatment regime
and outcome parameters also different follow-up time-points. For this
reason we decided to combine time-points 4 and 6 weeks and 8 and 12
weeks. Using these periods of follow-up we were able to compare the
effect sizes of the different treatments as shown in table 1 and 2.
Conclusion: Comparing the efﬁcacies of different treatments in
patients with hip OA at 4-6 weeks and 8-12 weeks we showed no
statistical differences. The differences in efﬁcacy between the treatment
